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Abstract
Background: The control of proliferation, differentiation and survival of normal and malignant
cells in the tumour microenvironment is under the control of a wide range of different factors,
including cell:cell interactions, cytokines, growth factors and hormonal influences. However, the
ways in which these factors interact are poorly understood. In order to compare the effects of
multiple variables, experimental design becomes complex and difficult to manage. We have
therefore evaluated the use of a novel approach to multifactorial experimental design, the Taguchi
methods, to approach this problem.
Method: The Taguchi methods are widely used by quality engineering scientists to compare the
effects of multiple variables, together with their interactions, with a simple and manageable
experimental design. In order to evaluate these methods, we have used a simple and robust system
to compare a traditional experimental design with the Taguchi Methods. The effect of G-CSF, GM-
CSF, IL3 and M-CSF on daunorubicin mediated cytotoxicity in K562 cells was measured using the
MTT assay.
Results: Both methods demonstrated that the same combination of growth factors at the same
concentrations minimised daunorubicin cytotoxicity in this assay.
Conclusions: These findings demonstrate that Taguchi methods may be a valuable tool for the
investigation of the interactions of multiple variables in the tumour microenvironment.
Introduction
The control of proliferation, differentiation and survival
of normal and malignant cells is under the control of a
wide range of different factors. These include cell:cell
interactions, immune regulatory factors, hormonal influ-
ences, and local environmental influences. However, the
way in which these factors interact to regulate the dynam-
ics of the malignant cell population are poorly under-
stood. It is important to identify important factors and the
way that they interact in order to rationalise treatment and
develop new therapeutic options. However, one of the
main problems is the difficulty in designing experiments
to compare the effects and interactions of multiple varia-
bles. For example, a traditional experimental design to
compare seven independent variables at three different
concentrations each requires a large number of individual
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experiments (2187 experiments). The logistical and
resource implications of this experimental design make
these experiments very difficult to carry out. We have
investigated the use of an alternative approach to experi-
mental design, the Taguchi Methods [1]. Taguchi methods
use orthogonal array distribution to design an experiment
producing smaller, less costly experiments that have a
high rate of reproducibility. A study involving 7 factors at
3 different concentrations can be conducted with only 18
individual experiments. Besides being efficient, the proce-
dures for using Taguchi designs and methods are straight-
forward and easy to use. These methods have previously
been used in PCR optimisation [2,3], baculovirus expres-
sion [4], ball and socket prosthesis design for total hip
replacement surgical procedure [5], ELISA optimisation
[6], and also in the evaluation of medical diagnostic tests
[7,8].
We have therefore used a simple and reproducible assay,
the MTT assay, to evaluate whether the Taguchi methods
can be used to investigate the effect of G-CSF, GM-CSF,
IL3 and M-CSF on daunorubicin mediated cytotoxicity in
K562 cells.
Taguchi Methods
Taguchi methods consist of 3 phases: designing the exper-
iment, running and analysing, and confirming and vali-
dating the assumptions. After selecting the variables to be
studied, Taguchi methods depend on distributing the fac-
tors under study in an orthogonal array, which distributes
the variables (factors) in a balanced manner. Examining a
typical orthogonal array (Table 1), where each factor has
2 levels or concentrations, reveals that each level has an
equal number of occurrences within each column. For
each column of the orthogonal distribution below, level 1
occurs four times, and level 2 occurs four times as well [1].
This idea of balance goes farther than meaning simply an
equal number of levels within each column. The relation-
ship between one column and another is arranged so that
for each level within one column, each level within any
other column occurs an equal number of times as well.
With reference to Table 1, it can be observed that factor A
is assigned to column 1, and for A at level 1, factor B is at
level 1 twice and at level 2 twice. The same is true for factor
A at level 2. Looking at the last column, the same relation-
ship between factors A and G is also noted. No matter
which two columns are selected, the same will be true. The
ramifications of this orthogonality among columns are
the basis of the statistical independence of orthogonal
arrays; hence the effect of each factor can be separated
from the others. Therefore, an estimation of the effect of
any one particular factor tends to be accurate and repro-
ducible because the estimated effect does not include the
influence of other factors. Furthermore, each factor can be
assigned a significance weight to denote its importance in
affecting the end result of the experiment.
Each array can be identified by the form LA(BC), the sub-
script L, which is designated by A, represents the number
of experiments that would be conducted using this design,
B denotes the number of levels or concentrations within
each column which denotes how many levels or concen-
trations could be investigated, while the letter C identifies
the number of columns available within the orthogonal
array which indicates how many factors or variables could
be included in the experiment [1]. For example the
orthogonal array L8(27) means that 8 experimental runs
are needed to investigate 7 different factors, each of which
is set at 2 predetermined levels or concentrations (Table
1). The statistical independence of these arrays enables the
effect of each factor to be separated from the others, the
effects to be accurate and reproducible because the esti-
mated effect does not include the effects of other factors
and the interactions between these factors to be
determined.
Level average analysis, as described by Taguchi [1] is one
of the techniques used to explore the results of the
Table 1: Orthogonality. The relationship between one column and another is arranged so that for each level within one column, each 
level within any other column occurs an equal number of times as well. Factor A, at level 1 occurs 4 times and at level 2 occurs 4 times 
as well. This equal occurrence is true for all factors involved in any orthogonal array.
ABCDEFG R e s u l t s
11111111 Y 1
21112222 Y 2
31221122 Y 3
41222211 Y 4
52121212 Y 5
62122121 Y 6
72211221 Y 7
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Taguchi methods. The name derives from determining the
average effect of each factor on the outcome of the exper-
iment. The goal is to identify those factors that have the
strongest effects and whether they exert their effect inde-
pendently or through interacting with other factors.
The equation below illustrates the method of calculating
the average effect of the experiment where Y1 is the result
of the first experiment, Y2 is the result of the second exper-
iment...etc, T is the overall average of the experiment, and
n is the number of the experimental runs.
For example, in order to calculate the effect of the two
concentrations of factor A, which are denoted A1 and A2,
where A1 is the average effect of factor A at concentration
1, A2 is the average effect of the same factor at concentra-
tion 2.
The relative impact of each factor (∆X) is simply the range,
which could be calculated as the difference between the
highest and lowest average response of each level. For
example the impact of factor A on the experiment out-
come is the difference between A1 & A2. (Known statisti-
cally as the range (∆)). The effects of all factors are
calculated in the same way, then arranged in a response
table, and examined for those factors with the strongest
effect (i.e. highest difference ∆), in order to separate them
from the weak effects. The breaking point between the
strong and weak effects is identified as a change in the pat-
tern of the difference between the ranges around the
median.
Besides determining the effects of the individual factors,
the same technique is used to determine the strength of
the impact of interactions on the product of the experi-
ment. The calculations are performed as the previous sec-
tion. In order to determine the interactions between A and
B, the average result of each 2 factors combined must be
determined. This is achieved through calculating the val-
ues of 4 points: A1B1, A1B2, A2B1, and A2B2, where
A1B1 is the average result generated due to the interaction
between concentration 1 of both factors, A1B2 is the
result of the interaction between concentration 1 of factor
A and concentration 2 of factor B, A2B1 represents the
interaction between factor A at concentration 2 and factor
B at concentration 1, while the fourth point A2B2 is the
interaction between both factors at concentration 2. These
4 points are then presented graphically to show the
strength or weakness of the interaction. Whether the inter-
action is weak, mild, or strong depends on whether the
two response lines are parallel, converging or intersecting,
with intersecting lines indicate a strong interaction, and
parallel lines indicate no interactions. Once the strong fac-
tors and interactions have been identified, an estimate of
their combined effect is calculated and the new experi-
ment is designed according to these assumptions. An
experiment is then carried out – referred here to as "con-
firmation run"- to validate the assumptions upon which
the new experiment was based. Conducting a confirma-
tion run and the comparison between the actual and the
predicted results is necessary. If however, the confirma-
tion results are disappointing, the planning phase must be
re-evaluated and the elements that went into the experi-
ment must be reviewed. A possible cause could be the
omission of a key factor from the experiment, for example
a powerful interaction was not considered. Another com-
mon cause is the setting of factor levels too close together
for the experiment. In these situations, the factor is found
insignificant during the analysis and is not accounted for
in the validation. The confirmation run should include
the best or preferred settings for mild and weak influences
as well as the strong ones. However, the less influential
factors are not incorporated into the prediction equation.
The reasoning is that the differences in the average results
may be due to experimental variation, and to incorporate
their effects could result in an overestimate of the pre-
dicted results. This could lead to a disappointing confir-
mation run when actually the results would have
validated the experiment analysis if the predicted results
had not been artificially high or low.
Methods
Cell Culture
K562 cells were cultured in RPMI-1640 medium supple-
mented by 10% (v/v) foetal bovine serum, 50 µg/ml pen-
icillin and 25 µg/ml streptomycin at 37°C in a humidified
atmosphere of 5% CO2-95% air. Cells were plated in 96
well microtiter plates (200 µl) at a density of 3 × 104 cells/
ml. Cells were co-cultured in the presence of 0.1 µg/ml
daunorubicin.
T 
Y1 Y2 ... Yn.
n
=
++ +
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Y1 Y2 Y3 Y4
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=
=
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Table 2: Concentrations of cytokines used.
12
A MCSF 100 U/ml 300 U/ml
B IL3 10 ng/ml 50 ng/ml
C GMCSF 10 ng/ml 50 ng/ml
D GCSF 10/ ng/ml 50 ng/mlInternational Seminars in Surgical Oncology 2004, 1:7 http://www.issoonline.com/content/1/1/7
Page 4 of 9
(page number not for citation purposes)
Table 3: The whole set of the 49 experiments carried out. Runs 1–16 included all possible combinations of all cytokines together (see 
text above). In runs 17–24 individual cytokine were added to the medium, two concentrations of each cytokine was tested. For example 
in run 17 MCSF was added to the medium at concentration 1 (100 U/ml), while in run 18 the same cytokine was added at concentration 
2 (300 U/ml). Runs 25 – 48 included the different possible interactions between each 2 cytokines, for example in run 25 both MCSF (100 
U/ml) and IL-3 (10 ng/ml) were added, in run 26 MCSF (100 U/ml) and IL-3 (50 ng/ml) were added, in run 27 MCSF (300 U/ml) and IL-
3 (10 ng/ml) were added, and in run 28 MCSF (300 U/ml) and IL-3 (50 ng/ml) were added. Experimental run 49 was carried out without 
adding any cytokines to the medium. All experimental runs were done in triplicate and repeated three times.
A MCSF B IL-3 C GMCSF D GCSF
11 1 1 1
21 1 2 2
31 2 1 2
41 2 2 1
52 1 1 2
62 1 2 1
72 2 1 1
82 2 2 2
91 1 1 2
10 1 2 1 1
11 1 1 2 1
12 1 2 2 2
13 2 1 1 1
14 2 2 2 1
15 2 1 2 2
16 2 2 1 2
17 1 0 0 0
18 2 0 0 0
19 0 1 0 0
20 0 2 0 0
21 0 0 1 0
22 0 0 2 0
23 0 0 0 1
24 0 0 0 2
25 1 1 0 0
26 1 2 0 0
27 2 1 0 0
28 2 2 0 0
29 1 0 1 0
30 1 0 2 0
31 2 0 1 0
32 2 0 2 0
33 1 0 0 1
34 1 0 0 2
35 2 0 0 1
36 2 0 0 2
37 0 1 1 0
38 0 1 2 0
39 0 2 1 0
40 0 2 2 0
41 0 1 0 1
42 0 1 0 2
43 0 2 0 1
44 0 2 0 2
45 0 0 1 1
46 0 0 1 2
47 0 0 2 1
48 0 0 2 2
49 0 0 0 0International Seminars in Surgical Oncology 2004, 1:7 http://www.issoonline.com/content/1/1/7
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Cytokines
In all experiments K562 cells were co-incubated in the
presence or absence of cytokines concentrations shown in
Table 2. All cytokines were purchased from R&D Systems,
UK.
MTT Assay
50 µl of MTT (3–4,5-dimethylthiazol 2,5-diphenyl tetra-
zolium bromide) (5 mg/ml) was then added to each well
and incubated at 37°C for 4 hours. The resulting deep
blue crystals were dissolved in 0.04 N HCl Isopropyl alco-
hol, and the absorbance measured using a scanning mul-
tiwell spectrophotometer at dual wavelength 570–630
nm. All measurements were performed in triplicates.
The % survival was calculated as
Classical Experimental Design
In classical experimental design the effect of each factor,
each concentration and each interaction is tested inde-
pendently. In order to investigate the full interactions
between 4 factors each at 2 concentrations, requires 81
individual experimental conditions to be performed. This
study used 49 combinations. The structure of the 49
experiments is shown in Table 3, where runs 1–16 were
designed to include all the different possible combina-
tions of all 4 cytokines together. For example, experimen-
tal run 3 was carried out after adding 100 U/ml MCSF, 50
ng/ml of both IL-3 and GMCSF, and 10 ng/ml GCSF to the
medium. Runs 17–24 included the effects of each
cytokine individually; two concentrations of each
cytokine were tested. For example in run 17,, only MCSF
was added to the medium at concentration 1 (100 U/ml),
while in run 18 the same cytokine was added at concen-
tration 2 (300 U/ml). Runs 25–48 were planned to
included the different possible interactions between each
2 cytokines, for example in run 25 both MCSF (100 U/ml)
and IL-3 (10 ng/ml) were added to the medium, in run 26
MCSF (100 U/ml) and IL-3 (50 ng/ml) were added, in run
27 MCSF (300 U/ml) and IL-3 (10 ng/ml) were added,
and in run 28 MCSF (300 U/ml) and IL-3(50 ng/ml) were
added. Finally, experimental run 49 was carried out with-
out adding any cytokines to the medium.
Taguchi Design L8(27)
In order to evaluate the performance of the Taguchi meth-
ods, eight experimental runs were carried out employing
the orthogonal array L8(27) to investigate the effect of 4
cytokines on the survival of K562 leukaemic cells. This
array accommodated 4 factors MCSF, IL-3, GMCSF and
GCSF. The interaction between MCSF and the other
cytokines was inserted into the array. As the 3rd column
was used to examine the interaction between MCSF and
IL-3, columns 5 and 6 were used to assess the interaction
between the same cytokine and GMCSF and GCSF respec-
tively (Table 4). All factors in this design were set at 10 and
50 ng/ml except MCSF, which was set at 100 and 300 U/
ml.
Results and Discussion
Results of the classical design
The results of the 49 experimental conditions are shown
in Figure 1. Columns 1–24 represent the simultaneous
combinations of the 4 cytokines. The toxicity of daunoru-
bicin was maximally enhanced by the addition of the four
cytokines to the medium i.e. MCSF at a concentration of
300 U/ml, IL-3 at a concentration of 50 ng/ml, GMCSF at
a concentration of 50 ng/ml, and GCSF at a concentration
of 50 ng/ml. This resulted in a highly significant reduction
of malignant cell survival, from 69% (the survival rate for
the control cells) to 39% (P <0.001).
Table 4: Taguchi method L8(27). This array accommodated 4 different factors (MCSF, IL-3, GMCSF, and GCSF) each at 2 different 
concentrations (see above). 8 experimental runs were carried out according to the combination of factors in the array, for example, in 
experimental run 1 the MTT assay was carried out after mixing the cells with 100 U/ml MCSF, 10 ng/ml IL-3, 10 ng/ml GMCSF, and 10 
ng/ml GCSF. The interaction between MCSF and the other three factors (IL-3, GMCSF and GCSF) was studied in this array.
A MCSF B IL3 AxB C GMCSF AxC AxD D GCSF
11111111
21112222
31221122
41222211
52121112
62122221
72211121
82212212
Absorbance of the cells exposed to the cytotoxic drug X 100 0%.
Absorbance of the control cells.International Seminars in Surgical Oncology 2004, 1:7 http://www.issoonline.com/content/1/1/7
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Experimental runs 1–16 show the different survival rates of K562 cells as a result of culturing the cells in medium enriched by  different combinations of the 4 cytokines (GMCSF, MCSF, IL-3, and GCSF) Figure 1
Experimental runs 1–16 show the different survival rates of K562 cells as a result of culturing the cells in medium enriched by 
different combinations of the 4 cytokines (GMCSF, MCSF, IL-3, and GCSF). The maximum cytotoxicity of daunorubicin was 
observed as a result of the addition of 300 U/ml of MCSF, and 50 ng/ml of the other 3 cytokines (experimental run 3). The 
maximum survival of the cells was observed when the concentration of GMCSF in this mixture was reduced to 10 ng/ml 
(experimental run 16). Experiments 17 – 48 suggested that MCSF interacts with the 3 other factors to affect daunorubicin 
cytotoxicity. This could be seen by comparing the effect of the individual factors (runs 17 – 24) with the effects of the addition 
of two factors simultaneously. For example, experimental run 30 shows the concurrent effect of both MCSF (100 U/ml) and 
GMCSF (50 ng/ml) that resulted in a survival that was significantly higher than that caused by any of the two factors alone (runs 
17, 18, 21 & 22). Experimental run 26 also represents the combined effects of MCSF (100 U/ml) and IL-3 (50 ng/ml), which 
resulted in a survival that was higher than the resulting survival of any of the two factors individually. Run 36; on the other 
hand, represents the increase in daunorubicin cytotoxicity as a result of the simultaneous addition of MCSF (300 U/ml) and 
GCSF (50 ng/ml). All these experimental runs were done in triplicate and repeated 3 times, the results are expressed as mean 
± SE.International Seminars in Surgical Oncology 2004, 1:7 http://www.issoonline.com/content/1/1/7
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The survival of K562 cells, using the 4 cytokines simulta-
neously was maximally enhanced by the addition of 300
U/ml MCSF, 50 ng/ml IL-3, 50 ng/ml GMCSF, and 50 ng/
ml GCSF. A significant improvement in cell survival from
69% to 76% (P 0.02) was observed
Taguchi analysis
The results of the 8 experiments of Taguchi's L8 series
(Table 5), were analysed in order to determine the mean
effect of each factor.
For example the mean effect of MCSF when added to the
medium at a concentration of 100 U/ml was computed as
follows:
When MCSF was added to the medium at a concentration
of 300 U/ml the mean effect was:
These computed values were used to construct a response
table (Table 6). This shows the average mean effect for
each factor and the relative impact or range of each factor
on the variability of the mean. This showed that the fol-
lowing concentrations were associated with lower survival
of the malignant cells; 300 U/ml MCSF was associated
with the survival of 59.4%, 50 ng/ml of IL-3 was associ-
ated with 57.5 % survival rate, 50 ng/m GMCSF resulted
in the survival of 60.8% of the cells, and finally 50 ng/ml
of GCSF was associated with 58.6% survival rate.
In order to determine the strong effects and separate them
from the weak ones, the response table was rearranged by
ranking the factors in order from the largest difference to
the smallest as it can be seen in Table 7. In this study the
interaction between MCSF and GCSF (AXD) has the great-
est effect on the survival of K562 cells. IL-3 (B) is next with
a difference between the ∆'s of 1.594. The interaction
between MCSF and IL-3 (AXB) was next followed by GCSF
(D). The difference between ∆B and ∆AXB is 0.507 (8.391-
7.884 = 0.507), if we continue farther to factor D the dif-
ference in effects jumps to 1.711 (7.884-6.173 = 1.711).
Therefore this point would be considered as the breaking
point. The factors to its left (AXD, B, and AXB) are the
important factors i.e. MCSF, IL-3, and GCSF. MCSF exerts
strong effects through interacting with both IL-3 and
GCSF.
In order to study each interaction incorporated into this
design, an interaction matrix for each interaction was con-
structed as described above; hence a 2 × 2 matrix was con-
structed for each interaction. For example to construct an
interaction matrix for MCSF and GCSF (AXD), four points
were computed A1D1, A1D2, A2D1, and A2D2 (Table 8).
A1D1 is the average result of the combined effect of MCSF
at a concentration 100 U/ml and GCSF at a concentration
of 10 ng/ml.
The interaction matrix AXD was then represented graphi-
cally (Fig 2) which showed intersecting lines indicating a
strong interaction. Both table 8 and fig 2 were further
studied to decide which combination suites the desired
outcome of the experiment; hence for the smaller the bet-
ter outcome, it is clear that 51.67% is the lowest survival
value in this matrix (Table 8), i.e. A2D2 (MCSF at a con-
centration of 300 U/ml and GCSF at a concentration of 50
ng/ml) is associated with the lowest survival rate of the
malignant cells. The interaction between MCSF and the
two other factors was further studied and the preferred
combinations for both interactions were A2B2 i.e. 300 U/
ml MCSF and 50 ng/ml IL-3, which was associated with
51.35% survival rate, and A2C2, i.e. MCSF at concentra-
tion 2 (300 U/ml) and 50 ng/ml GMCSF, which was asso-
ciated with 56.05% survival. The preferred settings
suggested by this analysis to optimise the cytotoxicity of
daunorubicin was combining the following factors
A2B2C2D2 i.e. MCSF at a concentration of 300 U/ml, IL-
3 at a concentration of 50 ng/ml GMCSF at a concentra-
tion of 50 ng/ml, and GCSF at a concentration of 50 ng/
ml.
An estimate of the predicted response (µ) based on the
selected levels was then computed. The calculations were
based on the overall average value (T) and the effect that
Table 5: the results of L8(27). Each experimental run was done in 
triplicate and repeated 3 times, the mean values were calculated 
and the results were expressed as mean ± SE. Y1 (experimental 
run 1), for example, = the mean survival of the cells at 100 U/ml 
MCSF, 10 ng/ml IL-3, 10 ng/ml GMCSF, and 10 ng/ml GCSF. The 
overall average of the experiment (T) was calculated as the mean 
of all eight experimental runs.
% survival
Y1 60.71 ± 5.9
Y2 67.83 ± 1.9
Y3 64.01 ± 1.1
Y4 63.51 ± 2.0
Y5 62.97 ± 4.3
Y6 72.27 ± 4.3
Y7 62.86 ± 1.1
Y8 39.84 ± 1.9
T6 1 . 7 5
A1
60.71 67.31 64.01 63.51 
4
=
+++
= 64 02 .%
A2
62.97 72.71 67.68 39.84 
4
=
+++
= 59 48 .%International Seminars in Surgical Oncology 2004, 1:7 http://www.issoonline.com/content/1/1/7
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each of the recommended levels of the strong factors and
interactions has on the overall average.
µ = T+(A2D2 - T)+(B2 - T)+(A2C2 - T)+(A2B2 - T)-(A2 -
T)-(A2 - T)-(A2 - T)-(B2 -T)-(C2-T).
The reason for subtracting the individual effects of factors
A, B, and C from the effects of A2B2 is that A2B2 is com-
prised of the effects of factor A, factor B and the interac-
tion itself. Unless the effects of the two factors are
subtracted these strong effects would be included twice
and resulting in an overestimation of the predicted result.
The predicted survival derived from the above prediction
equation was 43%. A confirmation run that produces a
%survival close to 43%would validate the assumptions of
this Taguchi method. The actual confirmation run, in fact,
resulted in 39.84% survival rate indicating the success of
the Taguchi experiment.
Further calculations were performed to determine
whether the outcome of other combinations could be pre-
dicted from the Taguchi experiment and confirmed by
analysis. The results are shown in Table 9 and show a close
approximation in each case.
Conclusion
The aim of this study was to evaluate the ability of the
Taguchi methods to investigate the effects of several fac-
tors simultaneously on the death and/or survival of the
malignant cells, and to compare this strategy against a tra-
ditional full experimental design.
A major finding of the study was that the Taguchi meth-
ods predicted the combination of factors that results in
the lowest survival of the malignant cells. This agreed with
the conclusions of the full experimental design but
required only eight individual experiments to pinpoint
this combination. However, it must be stressed that the
Table 6: Response table for the orthogonal array L8 (27). The average effect of each factor level is calculated and the range of effect of 
each factor is calculated as the difference between the two readings. The range of MCSF effect, for example = 64.02-59.48 = 4.53, the 
higher the range the stronger the effect of the factor. In this experiment the interaction between MCSF and GCSF had the strongest 
effect on the survival of cells.
A = MCSF B = IL3 AxB C = GMCSF AxC AxD D = GCSF
1 64.02% 65.95% 57.81% 62.64% 59.21% 56.76% 64.84%
2 59.48% 57.55% 65.69% 60.86% 64.29% 66.74% 58.66%
∆ 4.53 8.39 7.88 1.77 5.08 9.98 6.17
23 14
Table 7: Descending rearrangement of the response table according to strong and weak effects. The response table was rearranged 
according to the ∆s, and the difference between the ∆s was calculated and then scanned to determine the break point, which was 
identified as a change in the pattern of the difference between the ∆s around the median. The strong factors would be on the left hand 
side of the break point, marked in this table in bold.
AxD B = IL3 AxB D = GCSF AxC A = MCSF C = GMCSF
9.985% 8.391% 7.884% 6.173% 5.088% 4.533% 1.774%
1.594 0.507 1.711 1.085 0.555 2.759
Table 8: Interaction matrix AxD. The average effect of the four points of this interaction matrix on the survival of K562 cells. The 
preferred setting of this interaction that would maximise the cytotoxicity of daunorubicin is A2D2 i.e. 300 U/ml of MCSF and 50 ng/ml 
of GCSF. This combination would result in a survival of 51.67% of the cells.
D1 D2
A1 62.11% 65.92%
A2 67.56% 51.67%International Seminars in Surgical Oncology 2004, 1:7 http://www.issoonline.com/content/1/1/7
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Taguchi methods are not intended to be a replacement for
traditional experimental design, but if used as a compli-
mentary strategy can make analysis of complex interac-
tions feasible and practical. In this study, for example,
eight individual experiments produced a testable combi-
nation which required 49 individual experiments to pro-
duce in the traditional experimental design. In more
complex systems, only Taguchi methods become feasible.
For example, to study 13 factors at 3 different combina-
tions would require 1,594,323 individual experiments at
a cost for re agents alone of over 27 million pounds. If
Taguchi methods are used, this can be reduced to just 27
individual experiments at a cost of under 500 pounds.
We have described a novel experimental approach to stud-
ying the interactions of several factors on the cytotoxicity
of malignant cells. We show that the method is effective in
the determination of the optimum conditions, even in the
presence of multiple interactions. We anticipate that this
experimental strategy will have many applications in the
investigation of complex interactions. For example we
have used this strategy to model the complex testicular
microenvironment and the ability to support the survival
of acute lymphoblastic leukaemia cells (manuscript in
preparation). These sort of interactions are common in
the survival of malignant cells in vivo, and we propose that
the Taguchi methods may be a useful strategy to under-
stand these interactions in vitro, and to help devise and
implement new therapeutic strategies.
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Graphical presentation of interaction between AxD (MCSF  and GCSF) Figure 2
Graphical presentation of interaction between AxD (MCSF 
and GCSF). Intersecting lines of this graph indicate strong 
interaction. A2D2 is the preferred point on the graph i.e. the 
combination of these two factors to produce maximum dau-
norubicin cytotoxicity.
Table 9: Further comparison of the predicted values from the 
Taguchi Methods, and the result produced by experimental 
analysis.
Prediction Analysis
Experimental run 9 66.10% 70.35%
Experimental run 10 71.93% 74.38%
Experimental run 11 66.14% 63.36%
Experimental run 12 67.65% 65.36%
Experimental run 13 48.90% 45.69%
Experimental run 14 51.46% 55.22%
Experimental run 15 63.65% 74.88%
Experimental run 16 72.19% 76.74%